Subscribe

Clinical

Ajay S. Behl, PhD; Lorie A. Ellis, PhD; Dominic Pilon, MA; Yongling Xiao, PhD; Patrick Lefebvre, MA
A First Step Toward Improving the Complex Approach to Metastatic Prostate Cancer Management
Gary M. Owens, MD
Annlouise R. Assaf, PhD; Andrew G. Bushmakin, MS; Nina Joyce, PhD; Michael J. Louie, MD, MPH, MSc; Michael Flores, MPH; Margaret Moffatt, MPH
Hormone Therapy Remains Effective for Treating Menopausal Symptoms, May Save Overall Costs
JoAnn V. Pinkerton, MD, FACOG, NCMP
Michael J. Thorpy, MB, ChB; George Hiller, RPh
Improved Diagnosis and Treatment of Narcolepsy May Also Help to Reduce the Associated Costs
James T. Kenney, RPh, MBA
Kelly F. Bell, PharmD, MSPhr, MS; Katherine Cappell, PhD; Michael Liang, MS; Amanda M. Kong, MPH
Real-World Studies in Diabetes Needed to Improve Medication Adherence and Persistence
Brian Caveney, MD, JD, MPH
Kelvin Lingjet Tran, DO; Young In Park, DO; Shalin Pandya, DO; Navin John Muliyil, DO; Brandon David Jensen, DO; Kovin Huynh, DO; Quang T. Nguyen, DO, FACP, FACE, FTOS
The GLP-1 Receptor Agonists Are Cost-Effective for the Treatment of Type 2 Diabetes
Raymond Plodkowski, MD
Todd Williamson, MsC; Rajesh Kamalakar, MS; Augustina Ogbonnaya, MPH; Erin A. Zagadailov, PharmD, MS; Michael Eaddy, PharmD, PhD; Charlie Kreilick, MBA
The Challenge of Rosacea Treatment
Atheer A. Kaddis, PharmD
Jordan S. Orange, MD, PhD; Matt Johnson, BA; Barb Lennert, RN, BSN, MAOM; Katarzyna Shields, PharmD, MBA, BCOP, BCPS; Michael Eaddy, PharmD, PhD
A Useful Tool for Evaluating Disease Severity and Alternative Treatments Efficacy
Gary Branning, MBA
Dominic Pilon, MA; Ajay S. Behl, PhD; Lorie A. Ellis, PhD; Marie-Noëlle Robitaille, MA; Patrick Lefebvre, MA; Nancy A. Dawson, MD
Role of Real-World Evidence in Clinical Decision-Making for the Management of Advanced Prostate Cancer
Brian Caveney, MD, JD, MPH
Tope Olufade, PhD, MPH; Amanda M. Kong, MPH; Nicole Princic, MS; Paul Juneau, MS; Rucha Kulkarni, MPH; Kui Zhang, MD; Catherine Datto, MD, MS
The Opioid Epidemic: Healthcare Utilization and Cost Considerations
Jack E. Fincham, PhD, RPh
Jill R. Davis, MS; Bingcao Wu, MS; David M. Kern, PhD; Ozgur Tunceli, PhD; Kathleen M. Fox, PhD; John Horton, MS; Randall F. Legg, PharmD, MBA; Frank Trudo, MD, MBA
When an Outcome Is Overdetermined: Nonadherence, Utilization, and the Impetus for Research in COPD
Michael F. Murphy, MD, PhD
Page 4 of 14
Results 31 - 40 of 133
Copyright © Engage Healthcare Communications, LLC. All rights reserved.